focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

London pre-open: Slow start expected as oil slumps, US earnings ahead

Mon, 12th Jan 2015 07:59

UK stocks were expected to open more or less flat on Monday morning with investors taking a cautious approach after another slump in the price of oil.Markets were also treading lightly ahead of the unofficial start of US fourth-quarter earnings season, with aluminium giant Alcoai releasing its results after the closing bell on Wall Street. JPMorgan Chase & Co, Goldman Sachs and Well Fargo will also report this week.City sources predict the FTSE 100 will open just five points higher than Friday's close of 6,501.14.Brent crude was down 1.8% at $49.23 a barrel early on, extending losses from the lowest level in over five and a half years.Goldman Sachs cut its forecast for Brent in three months' time to just $42 a a barrel, and said that prices will "need to stay lower for longer"."Brent may have recovered to close back above $50 at the end of the week but with prices opening lower overnight [...] I think we're going to see plenty more volatility in the coming days as pressure mounts on oil producers to scale back production before prices get dangerously low," said analyst Craig Erlam from Alpari UK.Stocks to watchBiopharmaceutical group Shire has announced it will acquire NPS Pharmaceuticals for $5.2bn in cash, in a deal which Shire says will boost its revenue and earnings growth profile, while creating new business opportunities worldwide. The $46.00 per share price in the transaction represents a 51% premium to NPS Pharmaceuticals's share price of $30.47 on 16 December and Shire said the deal will be entirely funded by the firm's cash resources, as well as existing and new bank facilities.Oil and gas group Afren said it is looking at its "strategic options" for its 60% interest in the Barda Rash field, after analysis of the Kurdistan project showed a "material reduction" in reserve estimates. "Overall, the reservoirs have not performed according to previous expectations and the approved field development plan," Afren said.Housebuilder Taylor Wimpey said trading stabilised somewhat in the second half of 2014 as house-price growth eased, but painted an upbeat picture of the UK housing market as it lifted its margin guidance slightly. "As we enter 2015, we are encouraged by the more balanced market conditions, with a lower rate of price growth, which should create a healthy and more sustainable housing market," said chief executive Pete Redfern.

Related Shares

More News
10 May 2024 16:55

LONDON MARKET CLOSE: European stocks rally to record highs

(Alliance News) - Stock prices in London closed higher on Friday, spiking to another record high, with markets buoyed by US interest rate cut hopes.

10 May 2024 09:52

LONDON BROKER RATINGS: UBS raises Trainline, cuts Kingspan

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

9 May 2024 16:52

LONDON MARKET CLOSE: FTSE 100 climbs after doveish BoE decision

(Alliance News) - Stock prices in London closed higher on Thursday, with the FTSE 100 achieving another record high, supported by a Bank of England ra...

3 May 2024 13:37

UK dividends calendar - next 7 days

25 Apr 2024 08:16

UK's Persimmon confident for 2024, retains annual build target

Forward sales 1.75 bln stg vs 1.69 bln stg a year ago *

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.